Riskpilot← Back to searchSign inGet full accessKBS-ENT AS
ASActiveOrg 994264605Kjærlighetsstien 12, 3112 TønsbergGeneral medical practice activities · NACE 8621Est. 20091 employees
Revenue 2024
NOK 8,4M
+16% vs 2023
EBITDA margin
59.3%
+30% vs 2023
Equity ratio
85.1%
Financial strength
Net profit 2024
NOK 6,7M
+37% vs 2023
| Revenue | NOK 8,4M | +16% |
| EBITDA | NOK 5M | +30% |
| Net profit | NOK 6,7M | +37% |
| Total assets | NOK 22,5M | +33% |
| Equity | NOK 19,2M | +29% |
| Employees | 1 | — |
Legal name
KBS-ENT AS
Org number
994264605
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
9. juli 2009
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Yte legetjenester og alt som står i den forbindelse, samt deltagelse i andre selskap og virksomheter og alt hva dermed står i forbindelse.
Address
Kjærlighetsstien 12, 3112 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 692 | 6 492 | 7 085 | 7 212 | 8 353 |
| Staff expenses | −939 | −1 013 | −1 283 | −1 229 | −1 097 |
| EBITDA | 2 948 | 3 412 | 3 543 | 3 828 | 4 957 |
| Depreciation & amort. | −83 | −101 | −75 | −37 | −70 |
| EBIT | 2 865 | 3 311 | 3 469 | 3 791 | 4 887 |
| Net financials | 674 | 2 277 | −618 | 1 914 | 2 864 |
| Profit before tax | 3 539 | 5 588 | 2 851 | 5 705 | 7 750 |
| Tax | 632 | 752 | 778 | 842 | 1 094 |
| Net profit | 2 907 | 4 837 | 2 073 | 4 863 | 6 656 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 718 | 12 463 | 14 127 | 16 961 | 22 538 |
| Equity | 8 607 | 11 313 | 12 835 | 14 823 | 19 180 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 111 | 1 150 | 1 291 | 2 138 | 3 359 |
| Total debt | 1 111 | 1 150 | 1 291 | 2 138 | 3 359 |
EBITDA margin
59.3%
This company
15.8%
Market median
+275% vs market
20202024
Equity ratio
85.1%
This company
38.2%
Market median
+123% vs market
20202024
Return on equity
34.7%
This company
18.4%
Market median
+89% vs market
20202024
Net profit margin
79.7%
This company
8.1%
Market median
+884% vs market
20202024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20202024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BH Deputy Member | Deputy Member | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2009 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KBS-ENT AS 
FRITZØE KLINIKK SPESIALISTER ASBoard members of KBS-ENT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørn Herbern Sestøl | Deputy Member | 0 companies |
| Knut Breck Sestøl | Chairman | 0 companies |